Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan Shaheen

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Ejhaem|July 18, 2022
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalitiesMona Hassanein, Riad El Fakih, Walid Rasheed, et al.
Leukemia Research Reports|October 11, 2021
Improved survival in adolescents and young adults (AYA) patients aged 14-55 years with acute lymphoblastic leukemia using pediatric-inspired protocol - a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral centerAmr Hanbali, Ahmed Kotb, Riad El Fakih, et al.
Annals of Saudi Medicine|August 23, 2021
Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi ArabiaAhmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, et al.
Cytotherapy|September 22, 2023
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell sourceAhmed Kotb, Hazzaa Alzahrani, Ali Alahmari, et al.
International Journal of Hematologic Oncology|March 6, 2023
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemiaAmr Hanbali, Ahmed Kotb, Riad El Fakih, et al.
Bone Marrow Transplantation|September 7, 2019
Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patientsRiad El Fakih, Ahmed Kotb, Shahrukh Hashmi, et al.
Bone Marrow Transplantation|January 27, 2018
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomesNoura Alhashim, Mahmoud Aljurf, Mona Hassanein, et al.
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Current Practice of Oral Care for Hematopoietic Stem Cell Transplant Patients: A Survey of the Eastern Mediterranean Blood and Marrow Transplantation GroupHani Mawardi, Nathaniel Treister, Osama Felemban, et al.
Cancer|April 8, 2017
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemiaGiorgia Battipaglia, Annalisa Ruggeri, Radwan Massoud, et al.
Bone Marrow Transplantation|March 24, 2023
"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation"Majed Altareb, Moheeb Al-Awwami, Feras Alfraih, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Ejhaem|July 18, 2022
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalitiesMona Hassanein, Riad El Fakih, Walid Rasheed, et al.
Leukemia Research Reports|October 11, 2021
Improved survival in adolescents and young adults (AYA) patients aged 14-55 years with acute lymphoblastic leukemia using pediatric-inspired protocol - a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral centerAmr Hanbali, Ahmed Kotb, Riad El Fakih, et al.
Annals of Saudi Medicine|August 23, 2021
Outcomes of autologous stem cell transplantation for multiple myeloma in Saudi ArabiaAhmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, et al.
Cytotherapy|September 22, 2023
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell sourceAhmed Kotb, Hazzaa Alzahrani, Ali Alahmari, et al.
International Journal of Hematologic Oncology|March 6, 2023
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemiaAmr Hanbali, Ahmed Kotb, Riad El Fakih, et al.
Bone Marrow Transplantation|September 7, 2019
Outcomes of allogeneic hematopoietic cell transplant for acute myeloid leukemia in adolescent patientsRiad El Fakih, Ahmed Kotb, Shahrukh Hashmi, et al.
Bone Marrow Transplantation|January 27, 2018
Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomesNoura Alhashim, Mahmoud Aljurf, Mona Hassanein, et al.
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Current Practice of Oral Care for Hematopoietic Stem Cell Transplant Patients: A Survey of the Eastern Mediterranean Blood and Marrow Transplantation GroupHani Mawardi, Nathaniel Treister, Osama Felemban, et al.
Cancer|April 8, 2017
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemiaGiorgia Battipaglia, Annalisa Ruggeri, Radwan Massoud, et al.
Bone Marrow Transplantation|March 24, 2023
"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation"Majed Altareb, Moheeb Al-Awwami, Feras Alfraih, et al.
Pageof 4